应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GRAL GRAIL, Inc.
休市中 12-05 16:00:00 EST
100.98
-3.72
-3.56%
盘后
101.90
+0.92
+0.92%
19:50 EST
最高
105.00
最低
99.39
成交量
50.38万
今开
105.00
昨收
104.71
日振幅
5.36%
总市值
39.36亿
流通市值
31.37亿
总股本
3,898万
成交额
5,106万
换手率
1.62%
流通股本
3,106万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Grail, Inc.盘中异动 股价大涨5.09%报85.60美元
市场透视 · 11-19
Grail, Inc.盘中异动 股价大涨5.09%报85.60美元
异动解读 | 医疗科技公司Grail股价盘中大涨5.22%,受益于分析师目标价上调
异动解读 · 11-17
异动解读 | 医疗科技公司Grail股价盘中大涨5.22%,受益于分析师目标价上调
异动解读 | GRAIL股价盘中大涨7.43%,古根海姆上调评级至"买入"
异动解读 · 11-12
异动解读 | GRAIL股价盘中大涨7.43%,古根海姆上调评级至"买入"
华尔街顶级分析师最新评级报告:美国电话电报公司评级上调
环球市场播报 · 11-12
华尔街顶级分析师最新评级报告:美国电话电报公司评级上调
Grail, Inc.盘中异动 早盘股价大涨5.46%
市场透视 · 11-10
Grail, Inc.盘中异动 早盘股价大涨5.46%
Grail, Inc.盘中异动 急速下挫5.09%
市场透视 · 11-06
Grail, Inc.盘中异动 急速下挫5.09%
GRAIL宣布进行3.25亿美元的股票发行
环球市场播报 · 10-20
GRAIL宣布进行3.25亿美元的股票发行
Grail Pathfinder 2结果显示,Galleri®多癌种早期检测血液测试在增加USPSTF A和B推荐筛查时,癌症检测率提升超过七倍
美股速递 · 10-18
Grail Pathfinder 2结果显示,Galleri®多癌种早期检测血液测试在增加USPSTF A和B推荐筛查时,癌症检测率提升超过七倍
Grail Inc:预计截至9月30日拥有约5.47亿美元的现金、现金等价物、限制性现金和短期可投资证券
美股速递 · 10-17
Grail Inc:预计截至9月30日拥有约5.47亿美元的现金、现金等价物、限制性现金和短期可投资证券
Grail Inc:预计截至2025年9月30日的三个月收入在3570万到3670万美元之间
美股速递 · 10-17
Grail Inc:预计截至2025年9月30日的三个月收入在3570万到3670万美元之间
Grail(GRAL)盘前涨近12% 与三星达成战略合作
金吾财讯 · 10-16
Grail(GRAL)盘前涨近12% 与三星达成战略合作
三星与GRAIL战略合作,将癌症早期检测测试引入亚洲
老虎资讯综合 · 10-16
三星与GRAIL战略合作,将癌症早期检测测试引入亚洲
三星与GRAIL, Inc.宣布战略合作,将GRAIL的Galleri®多癌症早期检测测试引入亚洲
美股速递 · 10-16
三星与GRAIL, Inc.宣布战略合作,将GRAIL的Galleri®多癌症早期检测测试引入亚洲
Grail, Inc.盘中异动 早盘急速下挫5.03%
市场透视 · 10-14
Grail, Inc.盘中异动 早盘急速下挫5.03%
异动解读 | 癌症早筛公司GRAIL股价盘中大涨7.17%,现金消耗指引下调及业务增长提振投资者信心
异动解读 · 08-13
异动解读 | 癌症早筛公司GRAIL股价盘中大涨7.17%,现金消耗指引下调及业务增长提振投资者信心
异动解读 | 癌症早筛公司Grail股价盘中大涨7.17%,现金消耗指引下调及亏损收窄
异动解读 · 08-13
异动解读 | 癌症早筛公司Grail股价盘中大涨7.17%,现金消耗指引下调及亏损收窄
癌症早筛公司Grail(GRAL)更新2025年现金消耗指引至3.1亿美元主要由于其Galleri检测产品采用率提升及合
智通财经 · 08-13
癌症早筛公司Grail(GRAL)更新2025年现金消耗指引至3.1亿美元主要由于其Galleri检测产品采用率提升及合
癌症早筛公司Grail更新2025年现金消耗指引
环球市场播报 · 08-13
癌症早筛公司Grail更新2025年现金消耗指引
Grail, Inc.盘中异动 早盘大幅下挫5.03%报31.17美元
市场透视 · 08-11
Grail, Inc.盘中异动 早盘大幅下挫5.03%报31.17美元
Grail, Inc.盘中异动 早盘急速跳水5.01%
市场透视 · 08-06
Grail, Inc.盘中异动 早盘急速跳水5.01%
加载更多
公司概况
公司名称:
GRAIL, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Grail, Inc.于2015年9月11日在特拉华州注册成立。该公司是一家医疗保健公司,致力于通过开创癌症早期检测的新技术来拯救生命和改善健康。该公司建立了一个由科学家、工程师和医生组成的多学科组织,它正利用下一代测序(NGS)、人群规模临床研究以及最先进的计算机科学和数据科学的力量来克服医学的最大挑战之一。该公司利用该公司的平台技术,开发了一种多癌症早期检测血液检测方法,在临床研究中证明了从一次抽血中就可以检测出50多种癌症类型,并能高度准确地定位癌症信号。
发行价格:
--
{"stockData":{"symbol":"GRAL","market":"US","secType":"STK","nameCN":"GRAIL, Inc.","latestPrice":100.98,"timestamp":1764968400000,"preClose":104.705,"halted":0,"volume":503813,"hourTrading":{"tag":"盘后","latestPrice":101.9047,"preClose":100.98,"latestTime":"19:50 EST","volume":8180,"amount":825643.36,"timestamp":1764982237245},"delay":0,"floatShares":31063800,"shares":38982223,"eps":-11.617467,"marketStatus":"休市中","change":-3.725,"latestTime":"12-05 16:00:00 EST","open":105,"high":105,"low":99.39,"amount":51055104.54433,"amplitude":0.053579,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-11.617467,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":104.705,"preHourTrading":{"tag":"盘前","latestPrice":104.4263,"preClose":104.705,"latestTime":"08:59 EST","volume":489,"amount":50649.546645,"timestamp":1764943156193},"postHourTrading":{"tag":"盘后","latestPrice":101.9047,"preClose":100.98,"latestTime":"19:50 EST","volume":8180,"amount":825643.36,"timestamp":1764982237245},"volumeRatio":0.514619825633633,"impliedVol":0.9219,"impliedVolPercentile":0.256},"requestUrl":"/m/hq/s/GRAL","defaultTab":"news","newsList":[{"id":"2584737239","title":"Grail, Inc.盘中异动 股价大涨5.09%报85.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584737239","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584737239?lang=zh_cn&edition=full","pubTime":"2025-11-19 23:19","pubTimestamp":1763565580,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日23时19分,Grail, Inc.股票出现波动,股价急速拉升5.09%。截至发稿,该股报85.60美元/股,成交量12.1746万股,换手率0.31%,振幅6.41%。Grail, Inc.股票所在的生命科学行业中,整体跌幅为0.09%。其相关个股中,Inotiv, Inc.、Prophase Labs, Inc.、Personalis, Inc.涨幅较大,Mainz Biomed N.V.、Inotiv, Inc.、Prophase Labs, Inc.较为活跃,换手率分别为4.56%、1.74%、1.50%,振幅较大的相关个股有Mainz Biomed N.V.、Inotiv, Inc.、Endra Life Sciences Inc.,振幅分别为16.58%、13.76%、8.82%。Grail, Inc.公司简介:GRAIL Inc 是一家专注于开发早期癌症检测技术的医疗保健公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119231940a704ad57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119231940a704ad57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"1110370871","title":"异动解读 | 医疗科技公司Grail股价盘中大涨5.22%,受益于分析师目标价上调","url":"https://stock-news.laohu8.com/highlight/detail?id=1110370871","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110370871?lang=zh_cn&edition=full","pubTime":"2025-11-17 22:52","pubTimestamp":1763391140,"startTime":"0","endTime":"0","summary":"周一盘中,医疗科技公司Grail Inc股价大涨5.22%,引发市场关注。这一显著涨幅主要受益于券商分析师的积极评估。据悉,知名投资银行Canaccord Genuity当日大幅上调了Grail的目标股价,从此前的85美元提高至105美元,涨幅高达23.5%。这一举动表明分析师对Grail公司未来发展前景持乐观态度,从而提振了投资者信心。Grail公司专注于开发早期癌症检测技术,其创新的液体活检技术有望在癌症早期诊断领域取得突破。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GRAL"],"gpt_icon":0},{"id":"1169508049","title":"异动解读 | GRAIL股价盘中大涨7.43%,古根海姆上调评级至\"买入\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1169508049","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169508049?lang=zh_cn&edition=full","pubTime":"2025-11-12 23:12","pubTimestamp":1762960345,"startTime":"0","endTime":"0","summary":"周三盘中,生物技术公司GRAIL, Inc.股价大涨7.43%,引发市场关注。这一显著涨幅主要受益于华尔街知名投行古根海姆的最新研究报告。古根海姆将GRAIL的股票评级从\"中性\"上调至\"买入\",并给出100美元的目标价。值得注意的是,古根海姆强调,相比竞争对手,GRAIL具备显著的潜在数据壁垒。这一优势可能是推动投资者信心和股价上涨的关键因素。随着癌症早期检测市场的不断扩大,GRAIL的市场地位和技术优势可能会为公司带来长期增长潜力。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GRAL"],"gpt_icon":0},{"id":"2582308381","title":"华尔街顶级分析师最新评级报告:美国电话电报公司评级上调","url":"https://stock-news.laohu8.com/highlight/detail?id=2582308381","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582308381?lang=zh_cn&edition=full","pubTime":"2025-11-12 23:05","pubTimestamp":1762959900,"startTime":"0","endTime":"0","summary":"华尔街最受关注、且能影响市场走势的研究评级报告现已汇总一处。KeyBanc 银行将美国电话电报公司的评级从 “行业权重” 上调至 “增持”,目标股价定为 30 美元。伯恩斯坦公司首次覆盖辛塔斯公司,给予 “与大盘持平” 评级,目标股价定为 200 美元。该机构认为,辛塔斯是一家 “优质成长型公司”,但当前股价已处于高位。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-11-12/doc-infxemns6034755.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4162","BK4142","BK4214","LU1621768115.EUR","BK4550","LU1861558580.USD","LU1571399168.USD","BK4137","BK4141","FND","PGNY","IE00BSNM7G36.USD","LU1621768206.USD","LU1169589451.USD","LU1169590202.USD","OUT","LU0650527681.SGD","GRAL","BK4598","BK4234","CSR","BBWI","NTLA","LU0823417653.USD","BK4200","BK4215","BK4507","BK4548","BK4585","BK4503","CTAS","LU2506952170.USD","T","ATAT","AN","BK4556","LU0211326839.USD","BK4154","QUIK","BK4139","BK4535","LU1621767810.EUR","BK4588","NUVL","KMX","LU2506951958.HKD","CVNA","BHF","LU0175139822.USD","BK4534"],"gpt_icon":0},{"id":"2582338901","title":"Grail, Inc.盘中异动 早盘股价大涨5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582338901","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582338901?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:31","pubTimestamp":1762785111,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时31分,Grail, Inc.股票出现波动,股价大幅拉升5.46%。截至发稿,该股报83.74美元/股,成交量2.1143万股,换手率0.06%,振幅1.01%。Grail, Inc.股票所在的生命科学行业中,整体涨幅为0.21%。其相关个股中,Personalis, Inc.、Billiontoone, Inc.、Prenetics Global涨幅较大,Check-Cap Ltd.、Personalis, Inc.、Advanced Biomed Inc.较为活跃,换手率分别为0.56%、0.20%、0.19%,振幅较大的相关个股有Billiontoone, Inc.、Personalis, Inc.、Prenetics Global,振幅分别为8.47%、8.23%、4.62%。Grail, Inc.公司简介:GRAIL Inc 是一家专注于开发早期癌症检测技术的医疗保健公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110223151a6efbe06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110223151a6efbe06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2581493800","title":"Grail, Inc.盘中异动 急速下挫5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581493800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581493800?lang=zh_cn&edition=full","pubTime":"2025-11-06 23:37","pubTimestamp":1762443472,"startTime":"0","endTime":"0","summary":"北京时间2025年11月06日23时37分,Grail, Inc.股票出现波动,股价快速跳水5.09%。Grail, Inc.股票所在的生命科学行业中,整体跌幅为0.45%。其相关个股中,查尔斯河实验室、Precipio, Inc.、Prophase Labs, Inc.涨幅较大,Bioaffinity Technologies, Inc.、Advanced Biomed Inc.、Exagen Inc.较为活跃,换手率分别为1.48%、1.11%、0.74%,振幅较大的相关个股有Advanced Biomed Inc.、Caredx, Inc.、Check-Cap Ltd.,振幅分别为10.14%、9.01%、7.06%。Grail, Inc.公司简介:GRAIL Inc 是一家专注于开发早期癌症检测技术的医疗保健公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106233752975879ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106233752975879ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4198","BK4139","ADVB","GRAL"],"gpt_icon":0},{"id":"2576509878","title":"GRAIL宣布进行3.25亿美元的股票发行","url":"https://stock-news.laohu8.com/highlight/detail?id=2576509878","media":"环球市场播报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576509878?lang=zh_cn&edition=full","pubTime":"2025-10-20 21:59","pubTimestamp":1760968740,"startTime":"0","endTime":"0","summary":"美股周一早盘,生物科技公司GRAIL(GRAL)股价大涨23%,此前该公司宣布进行3.25亿美元的股票发行,以资助其商业和报销活动。公司预计此次募资加之三星的1.1亿美元投资将支持其运营至2030年。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:张俊 SF065","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-10-20/doc-infuqfte3539350.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SINA","BK4139","GRAL"],"gpt_icon":0},{"id":"1176533861","title":"Grail Pathfinder 2结果显示,Galleri®多癌种早期检测血液测试在增加USPSTF A和B推荐筛查时,癌症检测率提升超过七倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1176533861","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176533861?lang=zh_cn&edition=full","pubTime":"2025-10-18 06:10","pubTimestamp":1760739011,"startTime":"0","endTime":"0","summary":"Grail Pathfinder 2结果显示,Galleri®多癌种早期检测血液测试在增加USPSTF A和B推荐筛查时,癌症检测率提升超过七倍","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"1113432422","title":"Grail Inc:预计截至9月30日拥有约5.47亿美元的现金、现金等价物、限制性现金和短期可投资证券","url":"https://stock-news.laohu8.com/highlight/detail?id=1113432422","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113432422?lang=zh_cn&edition=full","pubTime":"2025-10-17 05:08","pubTimestamp":1760648909,"startTime":"0","endTime":"0","summary":"Grail Inc:预计截至9月30日拥有约5.47亿美元的现金、现金等价物、限制性现金和短期可投资证券。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"1155050093","title":"Grail Inc:预计截至2025年9月30日的三个月收入在3570万到3670万美元之间","url":"https://stock-news.laohu8.com/highlight/detail?id=1155050093","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155050093?lang=zh_cn&edition=full","pubTime":"2025-10-17 05:06","pubTimestamp":1760648767,"startTime":"0","endTime":"0","summary":"Grail Inc:预计截至2025年9月30日的三个月收入在3570万到3670万美元之间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2575446607","title":"Grail(GRAL)盘前涨近12% 与三星达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2575446607","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575446607?lang=zh_cn&edition=full","pubTime":"2025-10-16 21:28","pubTimestamp":1760621289,"startTime":"0","endTime":"0","summary":"金吾财讯 | Grail(GRAL)盘前股价拉升,暂报84.5美元,涨11.85%。消息面上,三星与Grail宣布达成战略合作,将Grail的Galleri®多癌早筛检测引入亚洲。三星物产和三星电子将向Grail投资1.1亿美元。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210625/MmNlMmI2NWNjNWI2MzQ2MDk3MTI0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/MmNlMmI2NWNjNWI2MzQ2MDk3MTI0.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4938b0cb8d08e9f7c72e7da79caa4313","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"293507","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"1168467442","title":"三星与GRAIL战略合作,将癌症早期检测测试引入亚洲","url":"https://stock-news.laohu8.com/highlight/detail?id=1168467442","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168467442?lang=zh_cn&edition=full","pubTime":"2025-10-16 20:50","pubTimestamp":1760619022,"startTime":"0","endTime":"0","summary":"三星子公司同意对该公司进行投资。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c14b607a2ef729dba99d9e6cdeff3225","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL"],"gpt_icon":0},{"id":"1110534328","title":"三星与GRAIL, Inc.宣布战略合作,将GRAIL的Galleri®多癌症早期检测测试引入亚洲","url":"https://stock-news.laohu8.com/highlight/detail?id=1110534328","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110534328?lang=zh_cn&edition=full","pubTime":"2025-10-16 20:24","pubTimestamp":1760617499,"startTime":"0","endTime":"0","summary":"三星与GRAIL, Inc.宣布战略合作,将GRAIL的Galleri®多癌症早期检测测试引入亚洲","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c14b607a2ef729dba99d9e6cdeff3225","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2575172202","title":"Grail, Inc.盘中异动 早盘急速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575172202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575172202?lang=zh_cn&edition=full","pubTime":"2025-10-14 21:31","pubTimestamp":1760448680,"startTime":"0","endTime":"0","summary":"北京时间2025年10月14日21时31分,Grail, Inc.股票出现波动,股价急速跳水5.03%。截至发稿,该股报66.90美元/股,成交量2.1136万股,换手率0.06%,振幅1.53%。Grail, Inc.股票所在的生命科学行业中,整体跌幅为0.71%。其相关个股中,Prenetics Global、Xwell, Inc.、Inotiv, Inc.涨幅较大,Endra Life Sciences Inc.、Ispecimen Inc.、Bioaffinity Technologies, Inc.较为活跃,换手率分别为7.58%、0.55%、0.55%,振幅较大的相关个股有Bioaffinity Technologies, Inc.、纽勤、Ispecimen Inc.,振幅分别为3.38%、2.18%、1.80%。Grail, Inc.公司简介:GRAIL Inc 是一家专注于开发早期癌症检测技术的医疗保健公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101421312194c8d167&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101421312194c8d167&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"1143644046","title":"异动解读 | 癌症早筛公司GRAIL股价盘中大涨7.17%,现金消耗指引下调及业务增长提振投资者信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1143644046","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143644046?lang=zh_cn&edition=full","pubTime":"2025-08-13 22:34","pubTimestamp":1755095669,"startTime":"0","endTime":"0","summary":"癌症早期筛查公司GRAIL, Inc.周三盘中股价大涨7.17%,引发市场关注。这一显著涨幅主要得益于公司发布的积极财务指引和业务增长数据。GRAIL公司更新了2025年的现金消耗指引,预计为3.1亿美元。值得注意的是,GRAIL还报告其净亏损同比大幅改善93%,这一进展主要得益于Galleri检测订单的显著增长。这不仅证明了公司产品的市场认可度不断提高,也表明其商业化战略正在取得实质性进展。随着癌症早期筛查市场的持续扩大,GRAIL有望进一步巩固其在这一领域的领先地位。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GRAL"],"gpt_icon":0},{"id":"1169514506","title":"异动解读 | 癌症早筛公司Grail股价盘中大涨7.17%,现金消耗指引下调及亏损收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=1169514506","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169514506?lang=zh_cn&edition=full","pubTime":"2025-08-13 22:34","pubTimestamp":1755095665,"startTime":"0","endTime":"0","summary":"癌症早筛公司Grail今日盘中股价大涨7.17%,引发市场关注。根据公司最新发布的财务更新,Grail将2025年的现金消耗指引下调至3.1亿美元,主要得益于其Galleri检测产品采用率的提升及合作伙伴关系的扩展。Grail公司专注于癌症早期筛查领域,其核心产品Galleri检测在市场上获得了良好的反响。投资者对Grail在癌症早筛技术领域的领先地位以及其商业化进程表现出高度认可,推动了股价的强劲上涨。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GRAL"],"gpt_icon":0},{"id":"2559600794","title":"癌症早筛公司Grail(GRAL)更新2025年现金消耗指引至3.1亿美元主要由于其Galleri检测产品采用率提升及合","url":"https://stock-news.laohu8.com/highlight/detail?id=2559600794","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559600794?lang=zh_cn&edition=full","pubTime":"2025-08-13 22:30","pubTimestamp":1755095402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2559998664","title":"癌症早筛公司Grail更新2025年现金消耗指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2559998664","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559998664?lang=zh_cn&edition=full","pubTime":"2025-08-13 22:29","pubTimestamp":1755095340,"startTime":"0","endTime":"0","summary":"癌症早筛公司Grail(GRAL)更新2025年现金消耗指引至3.1亿美元,主要由于其Galleri检测产品采用率提升及合作伙伴关系扩展。得益于检测订单增长,该公司报告净亏损同比改善93%。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:张俊 SF065","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-08-13/doc-infkwfyp3810947.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2558669725","title":"Grail, Inc.盘中异动 早盘大幅下挫5.03%报31.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558669725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558669725?lang=zh_cn&edition=full","pubTime":"2025-08-11 23:20","pubTimestamp":1754925620,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日23时20分,Grail, Inc.股票出现波动,股价大幅下跌5.03%。截至发稿,该股报31.17美元/股,成交量31.6924万股,换手率0.88%,振幅6.58%。Grail, Inc.股票所在的生命科学行业中,整体跌幅为0.36%。Grail, Inc.公司简介:GRAIL Inc 是一家专注于开发早期癌症检测技术的医疗保健公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811232021a4823e21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811232021a4823e21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2557830368","title":"Grail, Inc.盘中异动 早盘急速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557830368","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557830368?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:23","pubTimestamp":1754490223,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时23分,Grail, Inc.股票出现异动,股价大幅下跌5.01%。Grail, Inc.股票所在的生命科学行业中,整体跌幅为1.26%。其相关个股中,万基遗传、Mdxhealth Sa、Xwell, Inc.涨幅较大,万基遗传、Applied Dna Sciences, Inc.、Advanced Biomed Inc.较为活跃,换手率分别为6.21%、4.75%、1.83%,振幅较大的相关个股有万基遗传、Biodesix, Inc.、Personalis, Inc.,振幅分别为14.47%、10.40%、8.69%。Grail, Inc.公司简介:GRAIL Inc 是一家专注于开发早期癌症检测技术的医疗保健公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806222343a478eeec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806222343a478eeec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRAL","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://grail.com","stockEarnings":[{"period":"1week","weight":-0.0852},{"period":"1month","weight":0.1931},{"period":"3month","weight":1.7358},{"period":"6month","weight":1.6324},{"period":"1year","weight":3.506},{"period":"ytd","weight":4.6571}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Grail, Inc.于2015年9月11日在特拉华州注册成立。该公司是一家医疗保健公司,致力于通过开创癌症早期检测的新技术来拯救生命和改善健康。该公司建立了一个由科学家、工程师和医生组成的多学科组织,它正利用下一代测序(NGS)、人群规模临床研究以及最先进的计算机科学和数据科学的力量来克服医学的最大挑战之一。该公司利用该公司的平台技术,开发了一种多癌症早期检测血液检测方法,在临床研究中证明了从一次抽血中就可以检测出50多种癌症类型,并能高度准确地定位癌症信号。","exchange":"NASDAQ","name":"GRAIL, Inc.","nameEN":"GRAIL, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GRAIL, Inc.(GRAL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GRAIL, Inc.(GRAL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GRAIL, Inc.,GRAL,GRAIL, Inc.股票,GRAIL, Inc.股票老虎,GRAIL, Inc.股票老虎国际,GRAIL, Inc.行情,GRAIL, Inc.股票行情,GRAIL, Inc.股价,GRAIL, Inc.股市,GRAIL, Inc.股票价格,GRAIL, Inc.股票交易,GRAIL, Inc.股票购买,GRAIL, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GRAIL, Inc.(GRAL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GRAIL, Inc.(GRAL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}